# Digital Surgery

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/digital-surgery

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.digitalsurgery.com
- Total disclosed funding: $38M
- Latest round: Series C (Feb 12, 2018)
- Investors on record: 7

## About

Digital Surgery Limited specializes in developing digital surgical solutions that enhance surgical performance and decision-making through innovative technology, including AI and data visualization tools.Founded in 2013 and headquartered in London, UK, Digital Surgery Limited is focused on providing digital solutions for surgical teams. The company was acquired by Medtronic, Inc. in February 2020, although financial terms were not disclosed. The founders, Jean N and Sanjay Purkayastha, have prior experience in the healthcare technology sector. Digital Surgery has successfully completed a total of 8 deals, with its latest funding round being a Venture Debt raise of USD 70.00 mn, bringing the total amount raised to USD 6.94 mn.Digital Surgery Limited offers the Touch Surgery™ ecosystem, a suite of digital solutions designed to enhance surgical outcomes. This includes tools for capturing and accessing surgical videos, streamlining workflows, and providing performance insights to surgical teams at hospitals and surgical centers globally. Their technology is aimed at improving efficiency, training, and patient outcomes across North America, Europe, and Asia-Pacific.In the most recent fiscal year 2024, Digital Surgery Limited reported a revenue of USD 1,978,262.20 and an EBITDA of USD -37,673,759.40, demonstrating the financial activity within its operational scope.Following its acquisition by Medtronic, Digital Surgery Limited is poised for expansion into new markets and the development of additional products. The company plans to leverage its recent funding and technological advancements to enhance its product offerings, although specific release dates for new products have not been disclosed. Digital Surgery aims to deepen its presence in North America and expand into emerging markets by the end of 2024.

## Funding rounds

- Series C, Feb 12, 2018, $9.6M — Luma Bio-IT Management
- Series C, Aug 29, 2017, $20M — 8VC
- Series B, Nov 24, 2014, $5M — Redline Capital Management
- Series A, May 19, 2014, $1M — Episode 1 Ventures
- Series A, May 20, 2013, $2.3M — Balderton Capital
- Seed, Jan 1, 2013, $0M — Ballpark Ventures, Blueprint Health

## Investors

- Ballpark Ventures (https://capitalatlas.ai/funds/ballpark-ventures) — Seed
- Blueprint Health — Seed
- Balderton Capital (https://capitalatlas.ai/funds/balderton-capital) — Series A
- Episode 1 Ventures (https://capitalatlas.ai/funds/episode-1-ventures) — Series A
- Redline Capital Management (https://capitalatlas.ai/funds/redline-capital-management) — Series B
- 8VC (https://capitalatlas.ai/funds/8vc) — Series C
- Luma Bio-IT Management (https://capitalatlas.ai/funds/luma-bio-it-management) — Series C